A study by the Commonwealth Foundation found that patients with expensive treatment, such as palliative chemotherapy, were more likely to be turned away from hospice facilities. Some findings include The study found 61 percent of hospices would not accept patients who wanted chemotherapy, which can be used to help ease their pain in their dying … Continued
12/03/2012 Researchers at the Mayo Clinic have shown that ovarian cancer patients who were taking the common diabetes drug metformin survived longer than patients who weren’t on the drug. The research was published online in the journal Cancer. Two former OCRF grantees, Jeremy Chien, PhD, and Ramandeep Rattan, PhD, were among the paper’s authors. While metformin (also called Glucophage) … Continued
Using PET/CT scans, researchers looked at the brain function of 128 breast cancer patients. The study aimed to show that PET/CT is a useful tool to measure the presence of chemo brain. Read the abstract here and an article on the study here
11/27/2012 Research funded by Ovarian Cancer Research Fund, and published in Cancer Discovery, sheds new light on the molecular changes that convert harmless cells surrounding ovarian cancer cells into cells that promote tumor growth and metastasis. These cancer-supporting cells provide a novel target for treatment. The study’s lead author, Anirban Mitra, PhD, was funded by and … Continued
On Tuesday, the Department of Health and Human Services released three regulations related to implementation of health reform. One of these rules concerned guaranteed issue and a ban on pre-existing condition exclusion for adults. To learn more about these regulations see the article here The 131 pages of regulations can be found here
11/14/2012 Researchers at the National Cancer Institute have discovered a new way in which PARP inhibitors block cancer cell growth. They also discovered that three experimental PARP inhibitors vary widely in their ability to kill cancer cells. PARP inhibitors are a class of drugs that have shown promising results against ovarian cancer in women with … Continued
A study conducted by the Centers for Disease Control and Prevention showed that women were not aware of the non-gynecologic symptoms of gynecologic cancers, such as abdominal or back pain. Therefore, women did not recognize the urgency of seeking care for these symptoms. The study concludes that “[r]aising awareness of symptoms that can indicate gynaecologic … Continued
11/09/2012 A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, suggests that women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes than similar patients at low-volume hospitals. The improved survival rate is not dependent on … Continued
11/05/2012 In an article published in Cancer Prevention Research, a group of researchers in Australia examined the relationship between lifetime exposure to solar ultraviolet radiation (UVR) and ovarian cancer. The study concluded that women in the highest third of average daily ambient UVR exposure over their lifetime were at significantly lower risk of all epithelial … Continued
11/02/2012 In a study published in the journal Cancer Epidemiology, Australian researchers examined the relationship between tea drinking and the risk of ovarian cancer among southern Chinese women. The study, which included 500 women with serous ovarian cancer and 500 controls, found that regular tea consumption is associated with a reduced risk of ovarian cancer … Continued
10/29/2012 Research published in Cancer Epidemiology, Biomarkers, and Prevention shows that type II diabetes mellitus was not associated with risk of epithelial ovarian cancer. The risk ration was higher for type II diabetes with insulin use than for type II diabetes without insulin use. Diabetes seemed to be more strongly associated with noserous than serous … Continued
The National Comprehensive Cancer Network (NCCN) released new guidelines on palliative care for cancer patients. “The guidelines outline procedures for screening, assessment, palliative care interventions, reassessment, and after-death care.”
Get email updates about research news, action alerts, and ways to join the fight.
